中文 | English
Return
Total: 42 , 1/5
Show Home Prev Next End page: GO
Author:( Liangming ZHANG)

1.The attribution of acute exacerbation in the development of chronic obstructive pulmonary disease

Liangming ZHANG ; Minhua SHI

Chinese Journal of Postgraduates of Medicine 2009;32(4):23-25

2.Clinicopathological characteristics and treatment of stomach neoplasms with liver metastasis

Minghua SUI ; Liangming ZHANG

Journal of International Oncology 2013;(4):290-293

3.Practice of Implementing Quantized Assessment in Pharmacy of Our Hospital

Liangming ZHANG ; Yongzhi CHEN

China Pharmacy 2001;0(08):-

4.Determination of Serum Apolipoprotein A I, B 100 in Patients with Psoriasis Vulgaris

Shifa ZHANG ; Haitao ZHANG ; Liangming WANG

Chinese Journal of Dermatology 1994;0(02):-

5.Determination of Cassiaside B in Rabbit Plasma by HPLC

Songqing LIU ; Qing DAI ; Liangming ZHANG ;

China Pharmacy 2001;0(09):-

6.Serine protease HtrA2/Omi and cell death or survival

Huan DENG ; Liangming LIU ; Jixiang ZHANG

Chinese Journal of Pathophysiology 1999;0(09):-

7.The relationship of the difference of sol precursor protein expression and chemotherapy drug resistance in breast cancer

Ping SUN ; Aihong JIAO ; Liangming ZHANG

Chinese Journal of Primary Medicine and Pharmacy 2013;20(14):2083-2085,后插1

8.Significance of preventive transcatheter arterial immue-chemoembolization in primary liver cancer after operation

Ping SUN ; Liangming ZHANG ; Dengjun SUN ; Dongmei GENG

Journal of International Oncology 2009;36(6):477-479

9.The study about apoptosis of STI571 on NB4 in vitro

Zhijun ZHANG ; Xiujuan ZHAO ; Liangming MA ; Zhenhua QIAO

Cancer Research and Clinic 2007;19(z1):8-10

10.Effects of the concentrations of glutathione and the related mechanisms of arsenic trioxide (As2 O3) on Multidrug Resist-ance-associated Pr otein

Tao WANG ; Liangming MA ; Huaping ZHANG ; Yanyan NIU ; Ruirui REN

Journal of Chinese Physician 2014;(z1):1-5

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 42 , 1/5 Show Home Prev Next End page: GO